Nodular regenerative hyperplasia: a new serious antiretroviral drugs side effect?
Sandrine
Pierre-Francois
PF
Sylvie
Abel
A
André
Edouard
E
Abdoulaye
Diedhiou
D
Bernard
Liautaud
L
André
Cabie
C
D044966:Anti-Retroviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D056486:Chemical and Drug Induced Liver Injury; D016049:Didanosine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D015497:HIV-1; D006801:Humans; D006965:Hyperplasia; D008099:Liver / Q000473:pathology; D008107:Liver Diseases / Q000188:drug therapy / Q000473:pathology; D008115:Liver Regeneration; D008875:Middle Aged; D019829:Nevirapine / Q000009:adverse effects / Q000627:therapeutic use; D015215:Zidovudine / Q000009:adverse effects / Q000627:therapeutic use
D044966:Anti-Retroviral Agents; D015215:Zidovudine; D019829:Nevirapine; D016049:Didanosine